Product/Composition:- | Oxycodone tablets(ER) |
---|---|
Strength:- | 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg |
Form:- | Extended-Release Tablets |
Reference Brands:- | OxyContin, Roxicodone, Oxymorphone(US); OxyContin, OxyNorm(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Oxycodone ER tablets activate mu-opioid receptors in the brain and spinal cord, blocking pain signals and altering pain perception. Benefits include sustained, long-lasting pain relief, improved patient comfort, and reduced dosing frequency. It effectively manages severe, persistent pain when used responsibly under medical supervision.
Oxycodone ER (Extended-Release) tablets are approved in the US and EU for managing severe pain requiring long-lasting relief. In the US, brands like OxyContin are regulated by the FDA under strict control measures, supported by extensive clinical data and rigorous pharmacovigilance. In the EU, approval by the EMA involves detailed dossiers demonstrating safety, efficacy, and manufacturing quality, with strict regulations on prescribing and misuse prevention. Both regions enforce comprehensive licensing, risk management, and monitoring to mitigate abuse potential. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market access, ensuring adherence to European and American standards for safe, effective opioid therapy.